KRAS and neoplasm: PLK1 can also affect tumor cell growth by directly regulating tumor suppressor genes and oncogenes (including TP53, PTEN, KRAS, and c-MYC) through its kinase activity or by directly binding to specific domains of genes (Iliaki et al., 2021; Yim and Erikson, 2014).